Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hematopoietic growth factor synthesis refers to the biological process by which various cells produce hematopoietic growth factors[1]. These growth factors are primarily produced by bone marrow stromal cells such as fibroblasts and lymphocytes, as well as by monocytes, macrophages, endothelial cells, and other cell types[1][13]. The synthesis process results in a family of glycoproteins responsible for regulating the proliferation, differentiation, and maturation of hematopoietic progenitor cells in the bone marrow[3]. The produced growth factors include erythropoietin, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, interleukin-3, thrombopoietin, and steel factor, among others. These factors act through high-affinity cell surface receptors on hematopoietic cells[1]. Understanding this synthesis process has enabled the development of recombinant versions of these growth factors for therapeutic use in conditions involving bone marrow dysfunction, chemotherapy support, and various blood cell deficiencies[4][5].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hematopoietic growth factor synthesis.